Basics EyePoint Pharmaceuticals, Inc. Common Stock IPO Date: February 1, 2005 Sector: Healthcare Industry: Pharma Market Cap: $402.55M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.79% Avg Daily Range (30 D): $0.28 | 5.04% Avg Daily Range (90 D): $0.28 | 4.30% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): .66M Avg Daily Volume (90 D): .67M Trade Size Avg Trade Size (Sh.): 134 Avg Trade Size (Sh.) (30 D): 84 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 625 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $.79M Avg Inst. Trade (90 D): $.75M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.63M Avg Closing Trade (30 D): $.76M Avg Closing Trade (90 D): $.75M Avg Closing Volume: 125.7K         News May 16, 2025 @ 11:00 AM EyePoint Pharmaceuticals Reports Inducement Grants... Source: N/A Apr 30, 2025 @ 11:00 AM EyePoint to Report First Quarter 2025 Financial Re... Source: N/A Apr 16, 2025 @ 11:00 AM EyePoint Pharmaceuticals Reports Inducement Grants... Source: N/A Mar 27, 2025 @ 11:00 AM EyePoint to Present at 2025 RBC Capital Markets Op... Source: N/A Feb 17, 2025 @ 12:00 PM EyePoint Pharmaceuticals Reports Inducement Grants... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.65 $-.65 $-2.32 Diluted EPS $-.65 $-.65 $-2.32 Revenue $ 24.45M $ 11.59M $ 43.27M Gross Profit $ $ $ Net Income / Loss $ -45.2M $ -41.4M $ -130.87M Operating Income / Loss $ -48.84M $ -45.24M $ -145.85M Cost of Revenue $ $ $ Net Cash Flow $ -14.55M $ 19.87M $ -181.56M PE Ratio     Splits Dec 09, 2020:   10:1 Jun 11, 2008:   4:1